543520 — Global Longlife Hospital and Research Share Price
Last trade - 00:00- IN₹434.49m
- IN₹516.35m
- IN₹235.02m
- 21
- 61
- 31
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.67 | ||
| Price to Tang. Book | 0.67 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.81 | ||
| EV to EBITDA | 10.39 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.63% | ||
| Return on Equity | 3.18% | ||
| Operating Margin | 15.66% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 345.4 | 335.44 | 327.03 | 328.15 | 235.02 | n/a | n/a | -9.18% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +248.87 | -65.22 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Global Longlife Hospital and Research Limited is a multispecialty hospital operator providing medical and allied services. The Company offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, gi medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include cvts, joint replacement and ortho, general surgery, onco surgery, gi surgery, neurosurgery and ear, nose and throat. Its radiology services include mammography, ct scan, x-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- January 20th, 2012
- Public Since
- May 4th, 2022
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 10,500,000
- Address
- Nr.Bodakbev Garden, Pakwan Cross Road, AHMEDABAD, 380054
- Web
- https://globalhospital.co.in/
- Phone
- +91 7929708041
- Auditors
- Karma& Co LLP
Similar to 543520
Aashka Hospitals
Bombay Stock Exchange
ADS Diagnostic
Bombay Stock Exchange
Asarfi Hospital
Bombay Stock Exchange
Aspira Pathlab & Diagnostics
Bombay Stock Exchange
Chennai Meenakshi Multispeciality Hospital
Bombay Stock Exchange
FAQ
As of Today at 19:09 UTC, shares in Global Longlife Hospital and Research are trading at IN₹41.38. This share price information is delayed by 15 minutes.
Shares in Global Longlife Hospital and Research last closed at IN₹41.38 and the price had moved by -10.04% over the past 365 days. In terms of relative price strength the Global Longlife Hospital and Research share price has underperformed the S&P BSE 100 Index by -30.11% over the past year.
There is no consensus recommendation for this security.
Global Longlife Hospital and Research does not currently pay a dividend.
Global Longlife Hospital and Research does not currently pay a dividend.
Global Longlife Hospital and Research does not currently pay a dividend.
To buy shares in Global Longlife Hospital and Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹41.38, shares in Global Longlife Hospital and Research had a market capitalisation of IN₹434.49m.
Here are the trading details for Global Longlife Hospital and Research:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 543520
Based on an overall assessment of its quality, value and momentum Global Longlife Hospital and Research is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Global Longlife Hospital and Research. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -21.16%.
As of the last closing price of IN₹41.38, shares in Global Longlife Hospital and Research were trading -7.3% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Global Longlife Hospital and Research PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹41.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Global Longlife Hospital and Research's directors